Comprehensive search ChatGPT Online Scientific research tools Facebook Group Tools Telegram
Sign in Sign Up

Science Hub 每 Free Research Papers | Academic Community


[Elsevier] Setmelanotide in patients aged 2每5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial

maryamawadhpdc Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-29 00:18
Reward40points

  • Argente J, Verge C, Okorie U et al.
    Setmelanotide in patients aged 2每5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial
    The Lancet Diabetes & Endocrinology, 2024; 13, 29-37



    https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00273-0/abstract


    https://doi.org/10.1016/S2213-8587(24)00273-0


    Setmelanotide in patients aged 2-5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial
    Jes迆s Argente 1, Charles F Verge 2, Uzoma Okorie 3, Ilene Fennoy 4, Megan M Kelsey 5, Casey Cokkinias 6, Cecilia Scimia 6, Hak-Myung Lee 6, I Sadaf Farooqi 7


    Lancet Diabetes Endocrinol
    . 2025 Jan;13(1):29-37

    https://www.thelancet.com/journals/landia/article/PIIS2213-8587(24)00273-0/abstract




You can support us by donating, we would be very grateful.
Reply

Use magic Donate Report

All Reply1 Show all posts
DepOnion1415 Post time Half hour(s) ago | Show all posts

Waiting for confirmation

If the PDF has not been accepted after 72 hours, the system will automatically adopt it.
You can support us by donating, we would be very grateful.
Reply

Use magic Donate Report

maryamawadhpdc Lv.2
Junior Member

  • post

  • reply

  • points

    20

Same Category


Latest Reply

Announcement

Daily Top Contributors

Return to the list